Xiaomei Liu

499 total citations
27 papers, 344 citations indexed

About

Xiaomei Liu is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Xiaomei Liu has authored 27 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Surgery. Recurrent topics in Xiaomei Liu's work include Grey System Theory Applications (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Xiaomei Liu is often cited by papers focused on Grey System Theory Applications (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Xiaomei Liu collaborates with scholars based in China, United States and United Kingdom. Xiaomei Liu's co-authors include Naiming Xie, Shengming Deng, Xiaohua Wang, Pei Zhou, Wen Jiang, Qingyu Wu, Yijie Han, Chenglin Zhang, Xuexiang Wang and Penghui Zhou and has published in prestigious journals such as Journal of Clinical Investigation, Chemical Engineering Journal and IEEE Access.

In The Last Decade

Xiaomei Liu

22 papers receiving 339 citations

Peers

Countries citing papers authored by Xiaomei Liu

Since Specialization

Citations

This map shows the geographic impact of Xiaomei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomei Liu more than expected).

Fields of papers citing papers by Xiaomei Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomei Liu. The network helps show where Xiaomei Liu may publish in the future.

Co-authorship network of co-authors of Xiaomei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomei Liu. A scholar is included among the top collaborators of Xiaomei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomei Liu. Xiaomei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FDA‐Approved Pyrimidine‐Containing Drugs: Synthesis and Clinical Application 2025 ·Medicinal Research Reviews ·Yao Zhang, Xiaomei Liu, (unknown), (unknown), (unknown), (unknown)	0
2	Generative Adversarial Network Based on Self-Attention Mechanism for Automatic Page Layout Generation 2025 ·Applied Sciences ·Peng Sun, Xiaomei Liu, Liguo Weng, (unknown)	0
3	Spatial microbiome-metabolic crosstalk drives CD8+ T-cell exhaustion through the butyrate-HDAC axis in colorectal cancer 2025 ·Frontiers in Microbiology ·Xiaoyang Chen, (unknown), Guangyu Zhang, Dai Wang, (unknown), Yuxi Wang, Zhijun Huang, Xiaomei Liu	0
4	TAT-PBX1 fusion protein alleviates LPS-induced acute lung injury via AMPK-TFAM signaling activation 2025 ·Molecular Therapy ·Ziyi Chen, Xiaomei Liu, (unknown), Ying Xin, Jinyu Liu	0
5	A discrete time-varying grey Fourier model with fractional order terms for electricity consumption forecast 2024 ·Energy ·Xiaomei Liu, Sihan Li, (unknown)	10
6	Beyond first-line therapy: efficacy and safety outcomes of continuing immunotherapy in extensive stage small cell lung cancer after PD-L1 inhibitor progression 2024 ·Translational Oncology ·Jianfeng Peng, (unknown), Xiaomei Liu, (unknown), Yimeng Wang, (unknown), Ran Gao, (unknown)	2
7	Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in the treatment of recurrent ovarian cancer: A systematic review and meta-analysis 2024 ·Medicine ·Ya‐Fang Chen, Xiaomei Liu, Ying Hu, (unknown)	2
8	Anomaly detection system based on K-nearest neighbors and Naive Bayes 2024 ·Journal of Computational Methods in Sciences and Engineering ·Xiaomei Liu	0
9	Paintable graphene oxide-hybridized soy protein-based biogels for skin radioprotection 2023 ·Chemical Engineering Journal ·Daijun Zhou, Hui Liu, Lu Han, Di Liu, Xiaomei Liu, (unknown), Dan He, Zhihui Li, Xiong Lu, Chaoyang Jiang, (unknown)	17
10	Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer 2023 ·Radiation Oncology ·Jianfeng Peng, Lemeng Zhang, Liping Wang, Hui Feng, Dongmei Yao, Rui Meng, Xiaomei Liu, Xiaohua Li, Ningbo Liu, Bingxu Tan, Zhaoqin Huang, Shanshan Li, Xiangjiao Meng	14
11	Effectiveness and Safety of Toripalimab Combination Therapies for Patients With Chemo-Resistant Choriocarcinoma 2022 ·Frontiers in Oncology ·Xiaomei Liu, Xiuqin Li, Hui Qu, Shiyue Zhang, Ruizhe Zhang, (unknown)	4
12	Research on advertising content recognition based on convolutional neural network and recurrent neural network 2020 ·International Journal of Computational Science and Engineering ·Xiaomei Liu, F. Z. Qi	1
13	A nonlinear grey forecasting model with double shape parameters and its application 2019 ·Applied Mathematics and Computation ·Xiaomei Liu, Naiming Xie	52
14	Increased vessel perfusion predicts the efficacy of immune checkpoint blockade 2018 ·Journal of Clinical Investigation ·Xichen Zheng, (unknown), Xiaomei Liu, Shengming Deng, Pei Zhou, Xuexiang Wang, Chenglin Zhang, (unknown), Haitian Hu, Xiaolan Chen, Yijie Han, Yun Zhao, Steven H. Lin, Songbing Qin, Xiaohua Wang, Betty Y.S. Kim, Penghui Zhou, Wen Jiang, Qingyu Wu, Yuhui Huang	183
15	Hepatoid adenocarcinoma of the stomach: A case report and literature review 2015 ·Experimental and Therapeutic Medicine ·Xiaomei Liu, (unknown), Shun‐Li Li, (unknown)	11
16	Exploring the genes associated with the response to intravenous immunoglobulin in patients with Kawasaki disease using DNA microarray analysis 2014 ·Experimental and Molecular Pathology ·Yanlin Xing, Hong Wang, Xiaomei Liu, Xianyi Yu, Rui Chen, Ce Wang, (unknown), (unknown), (unknown)	3
17	Light propagation along the pericardium meridian at human wrist as evidenced by the optical experiment and Monte Carlo method 2014 ·Chinese Journal of Integrative Medicine ·Yifan Jiang, (unknown), Xiaomei Liu, (unknown), Songhao Liu	2
18	Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma 2012 ·International Journal of Oncology ·Xiaomei Liu, Aiyuan Wang, (unknown), Zhengwei Yuan, (unknown)	8
19	Extraction of Texture Feature and Identification Method of Landuse Information from SPOT 5 Image 2006 ·National Remote Sensing Bulletin ·(unknown), Xiaomei Liu	2
20	Preliminary Study on the Responses of Lake Water from the Western China to Climate change in the Future: Monte Carlo Analysis Applied in GCM Simulations and Lake Water Changes 2004 ·Journal of Lake Sciences ·Ge Yu, (unknown), (unknown), Xiaomei Liu, Sumin Wang, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact